Replies to post #92931 on NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Correction: "She must have good reason to suspect that such is true... with more than just the placebo efficacy effect on OS as the culprit."

I meant the possible unexpectedly high efficacy of the late administration of DCVax-L after crossover (not the placebo efficacy).

[HappyLibrarian]

I respect that you can reject the Feuerstein-Rutain rule and at the same time admit to serious problems with this Phase 3 trial.

The failure of NWBO to come clean about the reason for the screening halt even after they decided not to remediate the Phase 3 trial to get the screening halt lifted is VERY worrying.

We'll just have to see what happens but I do not think much will be left of the little shareholder equity that remains if NWBO is reduced to "torturing subgroups" for positive data.